Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.99.3 (
diaphorase
)
5,903
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Addition of NAD(+) to purified potato (Solanum tuberosum L.) mitochondria respiring alpha-ketoglutarate and malate in the presence of the electron transport inhibitor rotenone, stimulated O(2) uptake. This stimulation was prevented by incubating mitochondria with N-4-azido-2-nitrophenyl-aminobutyryl-NAD(+) (
NAP
(4)-NAD(+)), an inhibitor of NAD(+) uptake, but not by 1 mm EGTA, an inhibitor of external NADH oxidation. NAD(+)-stimulated malate-
cytochrome c reductase
activity, and reduction of added NAD(+) by intact mitochondria, could be duplicated by rupturing the mitochondria and adding a small quantity to the cuvette. The extent of external NAD(+) reduction was correlated with the amount of extra mitochondrial malate dehydrogenase present. Malate oxidation by potato mitochondria depleted of endogenous NAD(+) by storing on ice for 72 hours, was completely dependent on added NAD(+), and the effect of NAD(+) on these mitochondria was prevented by incubating them with
NAP
(4)-NAD(+). External NAD(+) reduction by these mitochondria was not affected by
NAP
(4)-NAD(+). We conclude that all effects of exogenous NAD(+) on plant mitochondrial respiration can be attributed to net uptake of the NAD(+) into the matrix space.
...
PMID:Exogenous NAD Effects on Plant Mitochondria: A Reinvestigation of the Transhydrogenase Hypothesis. 1666 22